Related Experiment Video
Updated: Jul 15, 2025

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
Beyond Participation: Evaluating the Role of Patients in Designing Oncology Clinical Trials
Eliya Farah1, Matthew Kenney1, Anris Kica1
1Life-Saving Therapies Network, 173 Heath Street, Ottawa, ON K1H 8L6, Canada.
Abstract:
Historically, subject matter experts and healthcare professionals have played a pivotal role in driving oncology clinical trials. Although patients have been key participants, their deliberate and active contribution to the design and decision-making process has been limited. This scoping review aimed to examine the existing literature to scope the extent of active patient engagement in the design of oncology clinical trials and its corresponding influence on trial outcomes. We conducted a systematic search using two databases, namely MEDLINE (Ovid) and EMBASE, to identify relevant studies exploring patient engagement in cancer-related clinical research design. We identified seven studies that met the eligibility criteria. The studies highlighted the benefits of active patient involvement, such as improved recruitment strategies, and the attainment of more patient-centered trial outcomes. The influence of patient involvement varied from tangible developments like patient-friendly resources to indirect impacts like improved patient experiences and potentially higher adherence to trial intervention. The future of clinical trials should prioritize patients' values and perspectives, with regulatory bodies fostering these practices through clear guidelines. As the concept of patient centricity takes root in oncology research, the involvement of patients should evolve beyond mere participation.
Insights
Active patient engagement in oncology clinical trial design improves outcomes and patient experiences. Prioritizing patient values is crucial for future cancer research, moving beyond simple participation.
Area of Science:
- Oncology
- Clinical Trials
- Patient Engagement
Background:
- Historically, oncology clinical trials relied on experts, with limited patient input in design.
- Patient participation was key, but their active role in decision-making was restricted.
Purpose of the Study:
- To review the literature on active patient engagement in oncology clinical trial design.
- To assess the influence of patient involvement on clinical trial outcomes.
Main Methods:
- Systematic literature search conducted in MEDLINE (Ovid) and EMBASE.
- Included studies focused on patient engagement in cancer clinical research design.
Main Results:
- Seven studies met eligibility criteria, highlighting benefits of active patient involvement.
- Benefits included enhanced recruitment strategies and more patient-centered outcomes.
- Patient involvement led to tangible developments (e.g., resources) and indirect impacts (e.g., adherence).
Conclusions:
- Future oncology trials must prioritize patient values and perspectives.
- Regulatory bodies should encourage patient centricity through guidelines.
- Patient involvement in research should expand beyond participation to active design contributions.
More Related Videos
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Cancer Survival Analysis
Treatment Resistant Cancers

